Symbol:
Hmcn1
Name:
hemicentin 1
RGD ID:
1564772
Description:
Predicted to enable axon guidance receptor activity. Predicted to be involved in several processes, including actin cytoskeleton organization; basement membrane organization; and homophilic cell adhesion via plasma membrane adhesion molecules. Predicted to act upstream of or within response to bacterium. Predicted to be located in several cellular components, including basement membrane; cell cortex; and muscle tendon junction. Predicted to be active in axon; neuronal cell body; and plasma membrane. Human ortholog(s) of this gene implicated in age related macular degeneration 1. Orthologous to human HMCN1 (hemicentin 1); INTERACTS WITH (+)-schisandrin B; 1,3-dinitrobenzene; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
hemicentin-1; LOC289094; RGD1564772; similar to OTTHUMP00000065631
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
HMCN1 (hemicentin 1)
HGNC
Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther
Mus musculus (house mouse):
Hmcn1 (hemicentin 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Hmcn1 (hemicentin 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
HMCN1 (hemicentin 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
HMCN1 (hemicentin 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Hmcn1 (hemicentin 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
HMCN1 (hemicentin 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
HMCN1 (hemicentin 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Hmcn1 (hemicentin 1)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
HMCN2 (hemicentin 2)
HGNC
Panther
Alliance orthologs 3
Homo sapiens (human):
HMCN1 (hemicentin 1)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Hmcn1 (hemicentin 1)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
hmcn1 (hemicentin 1)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
him-4
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
hmcn1
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PhylomeDB|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 13 65,165,532 - 65,634,681 (-) NCBI GRCr8 mRatBN7.2 13 62,615,461 - 63,084,524 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 13 62,615,461 - 63,084,524 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 13 65,251,755 - 65,716,143 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 13 66,522,976 - 66,980,354 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 13 63,789,725 - 64,243,174 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 13 67,799,791 - 68,360,664 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 13 67,799,791 - 68,360,664 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 13 72,762,698 - 72,782,812 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 Rnor_5.0 13 72,887,371 - 73,322,089 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 13 65,296,682 - 65,779,372 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 13 62,569,267 - 63,028,084 (-) NCBI Celera Cytogenetic Map 13 q21 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Hmcn1 Rat (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of HMCN1 mRNA] CTD PMID:31150632 Hmcn1 Rat 1,2-dichloroethane decreases expression ISO RGD:1618686 6480464 ethylene dichloride results in decreased expression of HMCN1 mRNA CTD PMID:28960355 Hmcn1 Rat 1,2-dimethylhydrazine decreases expression ISO RGD:1618686 6480464 1,2-Dimethylhydrazine results in decreased expression of HMCN1 mRNA CTD PMID:22206623 Hmcn1 Rat 1,3-dinitrobenzene decreases expression EXP 6480464 3-dinitrobenzene results in decreased expression of HMCN1 mRNA CTD PMID:21983209 Hmcn1 Rat 17beta-estradiol multiple interactions ISO RGD:1605323 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of HMCN1 mRNA; [Raloxifene Hydrochloride co-treated more ... CTD PMID:21185374|PMID:30165855 Hmcn1 Rat 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1618686 6480464 2,3',4,4',5-pentachlorobiphenyl results in increased expression of HMCN1 mRNA CTD PMID:31388691 Hmcn1 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1618686 6480464 Tetrachlorodibenzodioxin results in decreased expression of HMCN1 mRNA CTD PMID:21889950 Hmcn1 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of HMCN1 mRNA CTD PMID:32109520 Hmcn1 Rat 4,4'-sulfonyldiphenol increases expression ISO RGD:1618686 6480464 bisphenol S results in increased expression of HMCN1 mRNA CTD PMID:30951980 Hmcn1 Rat 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1618686 6480464 [bisphenol S co-treated with Tretinoin] results in decreased expression of HMCN1 mRNA CTD PMID:30951980 Hmcn1 Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of HMCN1 mRNA CTD PMID:31881176 Hmcn1 Rat aflatoxin B1 decreases methylation ISO RGD:1605323 6480464 Aflatoxin B1 results in decreased methylation of HMCN1 gene CTD PMID:27153756 Hmcn1 Rat aflatoxin B1 increases methylation ISO RGD:1605323 6480464 Aflatoxin B1 results in increased methylation of HMCN1 intron CTD PMID:30157460 Hmcn1 Rat all-trans-retinoic acid multiple interactions ISO RGD:1618686 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of HMCN1 mRNA; [bisphenol S co-treated more ... CTD PMID:30951980 Hmcn1 Rat alpha-Zearalanol multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of HMCN1 mRNA CTD PMID:35163327 Hmcn1 Rat aristolochic acid A decreases expression ISO RGD:1605323 6480464 aristolochic acid I results in decreased expression of HMCN1 mRNA CTD PMID:33212167 Hmcn1 Rat arsane decreases expression ISO RGD:1618686 6480464 Arsenic results in decreased expression of HMCN1 mRNA CTD PMID:19654921 Hmcn1 Rat arsane multiple interactions ISO RGD:1618686 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased secretion of HMCN1 more ... CTD PMID:37527016 Hmcn1 Rat arsenic atom decreases expression ISO RGD:1618686 6480464 Arsenic results in decreased expression of HMCN1 mRNA CTD PMID:19654921 Hmcn1 Rat arsenic atom multiple interactions ISO RGD:1618686 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased secretion of HMCN1 more ... CTD PMID:37527016 Hmcn1 Rat benzo[a]pyrene decreases expression ISO RGD:1618686 6480464 Benzo(a)pyrene results in decreased expression of HMCN1 mRNA CTD PMID:21569818 Hmcn1 Rat benzo[a]pyrene decreases expression ISO RGD:1605323 6480464 Benzo(a)pyrene results in decreased expression of HMCN1 mRNA CTD PMID:32234424 Hmcn1 Rat benzo[a]pyrene increases methylation ISO RGD:1618686 6480464 Benzo(a)pyrene results in increased methylation of HMCN1 intron CTD PMID:27901495 Hmcn1 Rat benzo[a]pyrene affects methylation ISO RGD:1605323 6480464 Benzo(a)pyrene affects the methylation of HMCN1 intron CTD PMID:30157460 Hmcn1 Rat benzo[a]pyrene increases methylation ISO RGD:1605323 6480464 Benzo(a)pyrene results in increased methylation of HMCN1 promoter CTD PMID:27901495 Hmcn1 Rat benzo[a]pyrene increases expression ISO RGD:1618686 6480464 Benzo(a)pyrene results in increased expression of HMCN1 mRNA CTD PMID:32417428 Hmcn1 Rat benzo[a]pyrene multiple interactions ISO RGD:1618686 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of more ... CTD PMID:27858113 Hmcn1 Rat benzo[a]pyrene affects expression ISO RGD:1605323 6480464 Benzo(a)pyrene affects the expression of HMCN1 mRNA CTD PMID:21714911 Hmcn1 Rat benzo[b]fluoranthene multiple interactions ISO RGD:1618686 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of more ... CTD PMID:27858113 Hmcn1 Rat benzo[e]pyrene increases methylation ISO RGD:1605323 6480464 benzo(e)pyrene results in increased methylation of HMCN1 intron CTD PMID:30157460 Hmcn1 Rat Benzo[k]fluoranthene decreases expression ISO RGD:1618686 6480464 benzo(k)fluoranthene results in decreased expression of HMCN1 mRNA CTD PMID:26377693 Hmcn1 Rat bis(2-ethylhexyl) phthalate increases expression ISO RGD:1618686 6480464 Diethylhexyl Phthalate results in increased expression of HMCN1 mRNA CTD PMID:28085963 Hmcn1 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of HMCN1 mRNA CTD PMID:25181051|PMID:34947998 Hmcn1 Rat bisphenol A decreases expression ISO RGD:1605323 6480464 bisphenol A results in decreased expression of HMCN1 mRNA CTD PMID:36232920 Hmcn1 Rat bisphenol A decreases expression ISO RGD:1618686 6480464 bisphenol A results in decreased expression of HMCN1 mRNA CTD PMID:38074096 Hmcn1 Rat bisphenol A affects methylation ISO RGD:1605323 6480464 bisphenol A affects the methylation of HMCN1 gene CTD PMID:31601247 Hmcn1 Rat bisphenol A increases expression ISO RGD:1618686 6480464 bisphenol A results in increased expression of HMCN1 mRNA CTD PMID:30245210|PMID:30951980 Hmcn1 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of HMCN1 mRNA CTD PMID:30816183 Hmcn1 Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of HMCN1 gene CTD PMID:28505145 Hmcn1 Rat bisphenol F multiple interactions ISO RGD:1618686 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of HMCN1 mRNA CTD PMID:30951980 Hmcn1 Rat bisphenol F decreases expression ISO RGD:1618686 6480464 bisphenol F results in decreased expression of HMCN1 mRNA CTD PMID:38685157 Hmcn1 Rat bisphenol F increases expression ISO RGD:1618686 6480464 bisphenol F results in increased expression of HMCN1 mRNA CTD PMID:30951980 Hmcn1 Rat cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of HMCN1 mRNA CTD PMID:33453195 Hmcn1 Rat calcitriol increases expression ISO RGD:1605323 6480464 Calcitriol results in increased expression of HMCN1 mRNA CTD PMID:16002434 Hmcn1 Rat carbon nanotube decreases expression ISO RGD:1618686 6480464 Nanotubes, Carbon analog results in decreased expression of HMCN1 mRNA; Nanotubes, Carbon results in decreased more ... CTD PMID:25554681 Hmcn1 Rat CGP 52608 multiple interactions ISO RGD:1605323 6480464 CGP 52608 promotes the reaction [RORA protein binds to HMCN1 gene] CTD PMID:28238834 Hmcn1 Rat chloroprene decreases expression ISO RGD:1618686 6480464 Chloroprene results in decreased expression of HMCN1 mRNA CTD PMID:23125180 Hmcn1 Rat choline multiple interactions ISO RGD:1618686 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... CTD PMID:20938992 Hmcn1 Rat chrysene multiple interactions ISO RGD:1618686 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of more ... CTD PMID:27858113 Hmcn1 Rat cisplatin increases response to substance ISO RGD:1605323 6480464 HMCN1 mRNA results in increased susceptibility to Cisplatin CTD PMID:25199881 Hmcn1 Rat daidzein multiple interactions ISO RGD:1605323 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with more ... CTD PMID:27424125 Hmcn1 Rat daidzein 7-O-beta-D-glucoside multiple interactions ISO RGD:1605323 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with more ... CTD PMID:27424125 Hmcn1 Rat dexamethasone decreases expression ISO RGD:1605323 6480464 Dexamethasone results in decreased expression of HMCN1 mRNA CTD PMID:25047013 Hmcn1 Rat dioxygen multiple interactions ISO RGD:1618686 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HMCN1 mRNA CTD PMID:30529165 Hmcn1 Rat diquat decreases expression ISO RGD:1618686 6480464 Diquat results in decreased expression of HMCN1 mRNA CTD PMID:36851058 Hmcn1 Rat dorsomorphin multiple interactions ISO RGD:1605323 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Hmcn1 Rat doxorubicin increases response to substance ISO RGD:1605323 6480464 HMCN1 mRNA results in increased susceptibility to Doxorubicin CTD PMID:25199881 Hmcn1 Rat ethanol increases expression ISO RGD:1605323 6480464 Ethanol results in increased expression of HMCN1 mRNA CTD PMID:31059573 Hmcn1 Rat folic acid multiple interactions ISO RGD:1618686 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... CTD PMID:20938992 Hmcn1 Rat genistein multiple interactions ISO RGD:1605323 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with more ... CTD PMID:27424125 Hmcn1 Rat genistein increases expression ISO RGD:1618686 6480464 Genistein results in increased expression of HMCN1 mRNA CTD PMID:32186404 Hmcn1 Rat genistein 7-O-beta-D-glucoside multiple interactions ISO RGD:1605323 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with more ... CTD PMID:27424125 Hmcn1 Rat glycitein multiple interactions ISO RGD:1605323 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with more ... CTD PMID:27424125 Hmcn1 Rat glycitin multiple interactions ISO RGD:1605323 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with more ... CTD PMID:27424125 Hmcn1 Rat L-methionine multiple interactions ISO RGD:1618686 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... CTD PMID:20938992 Hmcn1 Rat Lasiocarpine decreases expression ISO RGD:1605323 6480464 lasiocarpine results in decreased expression of HMCN1 mRNA CTD PMID:32234424 Hmcn1 Rat methapyrilene increases methylation ISO RGD:1605323 6480464 Methapyrilene results in increased methylation of HMCN1 intron CTD PMID:30157460 Hmcn1 Rat methotrexate increases response to substance ISO RGD:1605323 6480464 HMCN1 mRNA results in increased susceptibility to Methotrexate CTD PMID:25199881 Hmcn1 Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of HMCN1 gene CTD PMID:35440735 Hmcn1 Rat methylmercury chloride decreases expression ISO RGD:1605323 6480464 methylmercuric chloride results in decreased expression of HMCN1 mRNA CTD PMID:28001369 Hmcn1 Rat mono(2-ethylhexyl) phthalate decreases expression ISO RGD:1605323 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of HMCN1 mRNA CTD PMID:36695872 Hmcn1 Rat nickel atom decreases expression ISO RGD:1605323 6480464 Nickel results in decreased expression of HMCN1 mRNA CTD PMID:24768652|PMID:25583101 Hmcn1 Rat O-methyleugenol decreases expression ISO RGD:1605323 6480464 methyleugenol results in decreased expression of HMCN1 mRNA CTD PMID:32234424 Hmcn1 Rat ochratoxin A increases expression ISO RGD:1605323 6480464 ochratoxin A results in increased expression of HMCN1 mRNA CTD PMID:30559759 Hmcn1 Rat ozone multiple interactions ISO RGD:1618686 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased more ... CTD PMID:27106289|PMID:34911549 Hmcn1 Rat ozone decreases expression ISO RGD:1618686 6480464 Ozone results in decreased expression of HMCN1 mRNA CTD PMID:33026818 Hmcn1 Rat paclitaxel increases response to substance ISO RGD:1605323 6480464 HMCN1 mRNA results in increased susceptibility to Paclitaxel CTD PMID:25199881 Hmcn1 Rat paracetamol increases expression ISO RGD:1605323 6480464 Acetaminophen results in increased expression of HMCN1 mRNA CTD PMID:26690555 Hmcn1 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of HMCN1 mRNA CTD PMID:33387578 Hmcn1 Rat paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of HMCN1 mRNA CTD PMID:32680482 Hmcn1 Rat perfluorooctanoic acid multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of HMCN1 mRNA CTD PMID:35163327 Hmcn1 Rat progesterone decreases expression ISO RGD:1605323 6480464 Progesterone results in decreased expression of HMCN1 mRNA CTD PMID:21795739 Hmcn1 Rat raloxifene multiple interactions ISO RGD:1605323 6480464 [Raloxifene Hydrochloride co-treated with Estradiol] results in increased expression of HMCN1 mRNA CTD PMID:21185374 Hmcn1 Rat SB 431542 multiple interactions ISO RGD:1605323 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Hmcn1 Rat sodium arsenite increases expression ISO RGD:1605323 6480464 sodium arsenite results in increased expression of HMCN1 mRNA CTD PMID:38568856 Hmcn1 Rat sodium arsenite multiple interactions ISO RGD:1618686 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased secretion of HMCN1 more ... CTD PMID:37527016 Hmcn1 Rat tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of HMCN1 mRNA] CTD PMID:31150632 Hmcn1 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of HMCN1 mRNA CTD PMID:31150632 Hmcn1 Rat tetraphene multiple interactions ISO RGD:1618686 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of more ... CTD PMID:27858113 Hmcn1 Rat topotecan increases response to substance ISO RGD:1605323 6480464 HMCN1 mRNA results in increased susceptibility to Topotecan CTD PMID:25199881 Hmcn1 Rat trichostatin A increases expression ISO RGD:1605323 6480464 trichostatin A results in increased expression of HMCN1 mRNA CTD PMID:24935251|PMID:26272509 Hmcn1 Rat trichostatin A multiple interactions ISO RGD:1605323 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Hmcn1 Rat triclosan decreases expression ISO RGD:1605323 6480464 Triclosan results in decreased expression of HMCN1 mRNA CTD PMID:30510588 Hmcn1 Rat trimellitic anhydride decreases expression ISO RGD:1618686 6480464 trimellitic anhydride results in decreased expression of HMCN1 mRNA CTD PMID:19042947 Hmcn1 Rat triptonide increases expression ISO RGD:1618686 6480464 triptonide results in increased expression of HMCN1 mRNA CTD PMID:33045310 Hmcn1 Rat valproic acid affects expression ISO RGD:1605323 6480464 Valproic Acid affects the expression of HMCN1 mRNA CTD PMID:25979313 Hmcn1 Rat valproic acid decreases expression ISO RGD:1605323 6480464 Valproic Acid results in decreased expression of HMCN1 mRNA CTD PMID:28001369 Hmcn1 Rat valproic acid multiple interactions ISO RGD:1605323 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Hmcn1 Rat valproic acid increases expression ISO RGD:1605323 6480464 Valproic Acid results in increased expression of HMCN1 mRNA CTD PMID:24383497|PMID:24935251|PMID:26272509 Hmcn1 Rat vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of HMCN1 mRNA CTD PMID:23555832 Hmcn1 Rat vincristine increases response to substance ISO RGD:1605323 6480464 HMCN1 mRNA results in increased susceptibility to Vincristine CTD PMID:25199881 Hmcn1 Rat xylitol increases expression ISO RGD:1605323 6480464 Xylitol results in increased expression of HMCN1 mRNA CTD PMID:32275922 Hmcn1 Rat zoledronic acid decreases expression ISO RGD:1605323 6480464 zoledronic acid results in decreased expression of HMCN1 mRNA CTD PMID:24714768
(+)-schisandrin B (EXP) 1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (ISO) 1,3-dinitrobenzene (EXP) 17beta-estradiol (ISO) 2,3',4,4',5-Pentachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 4,4'-sulfonyldiphenol (ISO) acetamide (EXP) aflatoxin B1 (ISO) all-trans-retinoic acid (ISO) alpha-Zearalanol (EXP) aristolochic acid A (ISO) arsane (ISO) arsenic atom (ISO) benzo[a]pyrene (ISO) benzo[b]fluoranthene (ISO) benzo[e]pyrene (ISO) Benzo[k]fluoranthene (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) cadmium dichloride (EXP) calcitriol (ISO) carbon nanotube (ISO) CGP 52608 (ISO) chloroprene (ISO) choline (ISO) chrysene (ISO) cisplatin (ISO) daidzein (ISO) daidzein 7-O-beta-D-glucoside (ISO) dexamethasone (ISO) dioxygen (ISO) diquat (ISO) dorsomorphin (ISO) doxorubicin (ISO) ethanol (ISO) folic acid (ISO) genistein (ISO) genistein 7-O-beta-D-glucoside (ISO) glycitein (ISO) glycitin (ISO) L-methionine (ISO) Lasiocarpine (ISO) methapyrilene (ISO) methotrexate (ISO) methoxychlor (EXP) methylmercury chloride (ISO) mono(2-ethylhexyl) phthalate (ISO) nickel atom (ISO) O-methyleugenol (ISO) ochratoxin A (ISO) ozone (ISO) paclitaxel (ISO) paracetamol (EXP,ISO) paraquat (EXP) perfluorooctanoic acid (EXP) progesterone (ISO) raloxifene (ISO) SB 431542 (ISO) sodium arsenite (ISO) tetrachloromethane (EXP) tetraphene (ISO) topotecan (ISO) trichostatin A (ISO) triclosan (ISO) trimellitic anhydride (ISO) triptonide (ISO) valproic acid (ISO) vinclozolin (EXP) vincristine (ISO) xylitol (ISO) zoledronic acid (ISO)
Hmcn1 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 13 65,165,532 - 65,634,681 (-) NCBI GRCr8 mRatBN7.2 13 62,615,461 - 63,084,524 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 13 62,615,461 - 63,084,524 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 13 65,251,755 - 65,716,143 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 13 66,522,976 - 66,980,354 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 13 63,789,725 - 64,243,174 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 13 67,799,791 - 68,360,664 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 13 67,799,791 - 68,360,664 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 13 72,762,698 - 72,782,812 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 Rnor_5.0 13 72,887,371 - 73,322,089 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 13 65,296,682 - 65,779,372 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 13 62,569,267 - 63,028,084 (-) NCBI Celera Cytogenetic Map 13 q21 NCBI
HMCN1 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 1 185,734,391 - 186,190,949 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 1 185,734,391 - 186,190,949 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 1 185,703,523 - 186,160,081 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 1 183,970,306 - 184,426,708 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 1 158,814,385 - 159,270,786 (+) NCBI Celera Cytogenetic Map 1 q25.3-q31.1 NCBI HuRef 1 156,938,491 - 157,394,637 (+) NCBI HuRef CHM1_1 1 187,122,845 - 187,579,213 (+) NCBI CHM1_1 T2T-CHM13v2.0 1 185,089,079 - 185,545,614 (+) NCBI T2T-CHM13v2.0
Hmcn1 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 1 150,438,251 - 150,869,568 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 1 150,438,275 - 150,869,186 (-) Ensembl GRCm39 Ensembl GRCm38 1 150,562,500 - 150,993,652 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 1 150,562,524 - 150,993,435 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 1 150,488,170 - 150,802,827 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 1 152,635,966 - 152,755,653 (-) NCBI MGSCv36 mm8 Celera 1 153,006,498 - 153,437,575 (-) NCBI Celera Cytogenetic Map 1 G1 NCBI cM Map 1 63.84 NCBI
Hmcn1 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955406 24,229,973 - 24,622,314 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955406 24,229,666 - 24,623,341 (+) NCBI ChiLan1.0 ChiLan1.0
HMCN1 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 1 63,529,719 - 63,992,614 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 1 63,211,135 - 63,673,640 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 1 161,254,948 - 161,717,526 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 1 165,407,909 - 165,870,219 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 1 165,522,384 - 165,869,148 (+) Ensembl panpan1.1 panPan2
HMCN1 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 7 18,798,802 - 19,254,847 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 7 18,798,796 - 19,253,786 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 7 18,318,234 - 18,776,558 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 7 18,532,233 - 18,990,765 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 7 18,532,242 - 18,990,049 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 7 18,440,588 - 18,897,706 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 7 18,548,519 - 19,007,053 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 7 18,679,642 - 19,137,567 (+) NCBI UU_Cfam_GSD_1.0
Hmcn1 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024409344 86,365,905 - 86,743,041 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936481 4,213,631 - 4,589,464 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936481 4,212,713 - 4,494,469 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
HMCN1 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 9 126,850,313 - 127,342,685 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 9 126,850,208 - 127,342,696 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 9 139,722,309 - 139,770,641 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
HMCN1 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 25 43,230,265 - 43,677,315 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 25 43,231,328 - 43,554,097 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666055 44,419,653 - 44,876,647 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Hmcn1 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 119 Count of miRNA genes: 69 Interacting mature miRNAs: 71 Transcripts: ENSRNOT00000030971 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1298066 Bp159 Blood pressure QTL 159 0.004 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 46088046 91088046 Rat 10755495 Bp387 Blood pressure QTL 387 3.78 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 34663461 87525369 Rat 1354655 Bp241 Blood pressure QTL 241 3.9 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 56056920 101056920 Rat 70220 Bp55 Blood pressure QTL 55 5.75 arterial blood pressure trait (VT:2000000) blood pressure measurement (CMO:0000003) 13 37374509 82374509 Rat 71119 Thym2 Thymus enlargement QTL 2 3.8 thymus mass (VT:0004954) thymus weight to body weight ratio (CMO:0000612) 13 46197976 84753113 Rat 61391 Bp5 Blood pressure QTL 5 5.6 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 13 22301875 67301875 Rat 4889861 Pur29 Proteinuria QTL 29 13.8 0.005 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 13 37415584 80753406 Rat 12879441 Bp396 Blood pressure QTL 396 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 13 45699983 90699983 Rat 619615 Bp80 Blood pressure QTL 80 0.0354 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 39754544 84754544 Rat 2303028 Bp329 Blood pressure QTL 329 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 13 58497872 73485113 Rat 1581570 Eae17 Experimental allergic encephalomyelitis QTL 17 4.1 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 13 8897350 101631289 Rat 70170 Eae14 Experimental allergic encephalomyelitis QTL 14 0.0024 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 13 23203448 68203448 Rat 61340 Bp25 Blood pressure QTL 25 4.2 0.004 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 34535218 79535218 Rat 1581573 Uae36 Urinary albumin excretion QTL 36 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 13 5994833 77046787 Rat 1549897 Stresp12 Stress response QTL 12 3.35 stress-related behavior trait (VT:0010451) number of approaches toward negative stimulus before onset of defensive burying response (CMO:0001960) 13 38433408 83433408 Rat 724564 Uae11 Urinary albumin excretion QTL 11 5.7 urine albumin amount (VT:0002871) urine albumin level (CMO:0000130) 13 59492522 77046890 Rat 7207885 Glom27 Glomerulus QTL 27 3.9 kidney glomerulus integrity trait (VT:0010546) kidney crescentic glomeruli count to kidney normal glomeruli count ratio (CMO:0002139) 13 20605871 101339738 Rat 738026 Lnnr5 Liver neoplastic nodule remodeling QTL 5 3.29 liver integrity trait (VT:0010547) liver remodeling tumorous lesion number (CMO:0001461) 13 59874408 85581182 Rat 1558644 Cm45 Cardiac mass QTL 45 3.6 0.002 heart mass (VT:0007028) heart wet weight (CMO:0000069) 13 23692969 68692969 Rat 70181 BpQTLcluster11 Blood pressure QTL cluster 11 6.922 arterial blood pressure trait (VT:2000000) absolute change in mean arterial blood pressure (CMO:0000533) 13 31241331 93395974 Rat 61349 Bp31 Blood pressure QTL 31 5.75 arterial blood pressure trait (VT:2000000) blood pressure measurement (CMO:0000003) 13 37374509 82374509 Rat 2303563 Bw89 Body weight QTL 89 6 body mass (VT:0001259) body weight (CMO:0000012) 13 32284471 77284471 Rat 1354621 Rf47 Renal function QTL 47 3.7 kidney renin amount (VT:0010559) kidney renin level (CMO:0002166) 13 30395351 101056920 Rat 1581554 Pur11 Proteinuria QTL 11 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 13 5994833 77046787 Rat 12879477 Bp401 Blood pressure QTL 401 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 13 37262092 82262092 Rat 1331750 Bp220 Blood pressure QTL 220 2.98 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 13 37415584 82415584 Rat 6893338 Cm76 Cardiac mass QTL 76 0 0.99 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 13 23692969 68692969 Rat 1641901 Alcrsp6 Alcohol response QTL 6 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 13 52362171 97362171 Rat 12879475 Bp400 Blood pressure QTL 400 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 13 61825626 106807694 Rat 1354666 Bp244 Blood pressure QTL 244 4.9 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 13 1 101056920 Rat
D13Got234
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 13 65,213,411 - 65,213,677 (+) Marker Load Pipeline mRatBN7.2 13 62,663,372 - 62,663,638 (+) MAPPER mRatBN7.2 Rnor_6.0 13 67,948,041 - 67,948,306 NCBI Rnor6.0 Rnor_5.0 13 72,909,200 - 72,909,465 UniSTS Rnor5.0 RGSC_v3.4 13 65,346,001 - 65,346,266 UniSTS RGSC3.4 Celera 13 62,617,160 - 62,617,425 UniSTS Cytogenetic Map 13 q21 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000030971 ⟹ ENSRNOP00000033710
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 13 62,616,476 - 63,084,524 (-) Ensembl Rnor_6.0 Ensembl 13 67,799,791 - 68,360,664 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000076697 ⟹ ENSRNOP00000068149
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 13 67,799,791 - 67,926,222 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000076776 ⟹ ENSRNOP00000067981
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 13 62,641,251 - 62,977,282 (-) Ensembl Rnor_6.0 Ensembl 13 67,926,219 - 68,253,251 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000093469
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 13 62,615,461 - 63,084,524 (-) Ensembl Rnor_6.0 Ensembl 13 67,799,800 - 68,360,552 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000093666 ⟹ ENSRNOP00000076253
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 13 67,800,968 - 67,819,835 (-) Ensembl
RefSeq Acc Id:
NM_001271292 ⟹ NP_001258221
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 13 65,165,532 - 65,634,519 (-) NCBI mRatBN7.2 13 62,615,461 - 63,084,524 (-) NCBI Rnor_6.0 13 67,799,791 - 68,360,664 (-) NCBI Rnor_5.0 13 72,762,698 - 72,782,812 (-) NCBI Rnor_5.0 13 72,887,371 - 73,322,089 (-) NCBI Celera 13 62,569,267 - 63,028,084 (-) NCBI
Sequence:
AGTCGCTGGCCTGGAGCGCGGCGGCGGCGGAGGCGGCACCGCAGGCTCGCAGCGTCCCCGGGGCATGGACCCGGCGCTCTGCCGGCACTCGGCTACTCGCAGCTCCCTGCACGCGGCCGCCTAGAGCC CACGACCTACTCAGCCGGACAAAAGGCGCTGCATCCTTGCCCAGCCCAGCCCAGCTCCTGGAAGGACCCGGGCTCTGGGCTGGTCCTCATCTCCTTCTCCGCTCCAAACTTTGAGTTAGTTCAGAGAC TGCAAAAAGCTGATGAGGCACCGGGGAGGAAGTCCTCTGCTTGCTGCTGAGGAGTAAGCACAGTGCTAAGGAGCTCAGGGCAAAGAGAAAAGCAGCGAGCAAAACAAGAAAAGAAAAGAAAAAAAAAT GATTGCCCAGGAACTGGTCCACACAGTTTTCCTGGTGGCTCTTTTTCATTCTTCCCTAGCTGGAGTTGGGACCCCGCAGTCGGAGAGCAGGGCTGAGGAGATTCCGGAGGGGGCGTCCACGTTGGCTT TTGTGTTTGATGTGACTGGCTCCATGTATGATGATTTAGTTCAGGTTATTGAAGGGGCTTCCAAAATTTTGGAGACGTCTTTGAAAAGACCTAAGAGACCTCTTTACAACTTTGCTTTGGTGCCCTTC CATGATCCAGAAATCGGTCCAGTGACAATTACCACAGATCCGAAAAAATTTCAGTATGAACTGAGAGAACTGTATGTTCAGGGAGGTGGCGATTGTCCAGAAATGAGTGTCGGGGCTATAAAGATTGC CCTGGAAATTTCTCTTCCTGGTTCCTTCATCTATGTTTTCACTGATGCACGATCCAAGGATTATCGTCTCACCCATGAGGTGCTGCAGCTTATCCAGCAGAAACAATCCCAAGTGGTATTTGTGCTCA CTGGAGACTGTGATGACAGGAACCATATTGGATACAAAGTCTATGAAGAAATTGCTTCTACAAGTTCTGGTCAAGTGTTCCATCTGGACAAAAAGCAAGTAAATGAGGTGTTGAAGTGGGTGGAAGAA GCGGTGCAGGCCTCCAAGGTTCACCTCTTATCCACCGACCATTTGGAACACGCTGTAAATACTTGGAAAATTCCTTTTGATCCCAGCCTCAAAGAAGTTACTGTGTCCCTGAGTGGCCCTTCTCCCGT GATTGAAATTCGCAATCCTTTCGGGAAGCTGATAAAAAAGGGGTTTGGCTTGAATGAGCTGTTAAATATCCATAACTCTGCCAAGGTGGTGAACGTCAAAGAGCCCGAAGCTGGAATGTGGACAGTGA AGACCTCCAGCAGTGGAAGGCATTCTGTTCGCCTCACCGGTCTCAGCACTATCGATTTCCGAGCTGGCTTTTCTCGAAAGCCCACGCTGGACTTCAAAAAAACAATGAGCAGACCCGTGCAAGGGATA CCTACGTATGTGCTACTGAACACCTCTGGAATCTCTAGTCCAGCTAGAGTAGATCGCCTCGAACTTCTGAGTATCTCAGGGGGATCTCTTAAGACCATTCCCGTCAAACATTACCCAGATCGGAAACC TTACGGCATCTGGAATATCTCTGACTTCATTCCACCAGATGAAGCTTTCTTTCTCAAGGTGACAGGCTATGACAAAGAGGATTATCTCTTCCAGAGAGTGTCAAGCGTTTCCTTTTCCAGCATTGTCC CAGATGCTCCCAAAGTTACAATGCCCACGAGGACCTCAGGATACTACCTACAGCCAGGCCGAATCCTCTGCTCGGTTGAGAGTCTTTTGCCCTTTACTTTGAGCTTCGTGAGAAATGGAATTGCCCTG GGAGTAGAGCAATATTTAAAAGAATCTGCCAGTGTGCCTTGGGATTTCCCAAAGGTGACGTTGTCTGACGAGGGCTTCTACGAGTGTATTGCTATGAACAGCGCAGGAACTGGACGGGCGCAGACATT TTTTGATGTATCAGAGCCCCCTCCGATCATCCAAGTGCCTAATAATGTAACAGTCACTCCTGGAGAAAGAGCAGTTTTGGCGTGTCTCGTCATCAGTGCCGTGGATTATAACCTAACCTGGCAGAGGA GTGGCAGGGATGTCCGGCTAGCAGACTCAGCAAGAATTAGGACCCTGGCCAACCTCTCCCTGGAGCTGCGGAGTGTGAAAATTGGTGATGCTGGGGAGTACCGTTGTGTGGTTTCCAGTGAAGGGGGA TCGGCAGCAGCTTCGGTTTTCCTGACAGTACAAGAAAAACCCAAAGTCACCGTGATGCCCAGGAATCAGTCTTTCACAGGAGGGTCTGAGGTCTCCATCATGTGCTCTGCAACAGGCTATCCCAAACC AAAGATTGTCTGGACCATTAATGAGATGTTTATCCTGGGTTCACACAGATACAGGATGACCGCAGAAGGCACTTTATTCATCAAGAACGCAGTTCCCAAAGATGCAGGGACCTACAGTTGCCTGGCAA GCAATGAGGCCGGGACAGACGAGCAAACTTCCACTCTCAGATACATAGAAGCCCCAAAGTTGGTGGTAGTTCAGAGCGAGCTCTTGGTGGCCCTTGGGGATACAACAGTTATGGAATGTAAAACCTCT GGGATTCCCCCACCTCAAGTAAAGTGGTTCAAAGGAGATCTCGAGCTGAGGCCCTCGACGTTCCTCAGTATTGACCCTCTCATGGGTCTTTTGAAGATTCAAGAAACACAAGATCTGGATGCTGGCGA TTATACCTGTGTAGCCGCCAATGACGCTGGAAGAGCCACAGGCAGTCTAACTCTGGATGTAGGCTCACCTCCGGTTTTCATACAAGAACCTTCTGATGTGTCCATGGAAATTGGCTCCAATGTGACAT TACCTTGTTATGTTCAGGGTTATCCAGAACCAAAGATCAAATGGCGGAGATTGGACAACATGCCAGTTTTCTCAAAACCCTTTTCAGTTAGTTCCATCAGCCAGCTGAGAACAGGAGCTCTCTTTATT TCAAATTTATGGGCAAGTGATAAAGGAACGTACATCTGTGAAGCAGAAAACCAGTTTGGAAAAATACAGTCGCAGACAACAGTAACAGTGACAGGACTTGTTGCCCCACTTATTGGAATCAGCCCTTC CAAAGCCAGTGTGATTGAAGGACAGCCACTAACCTTGCCTTGTACTCTGTTGGCTGGAAATCCCATTCCAGAACGGCGGTGGATGAAGAACTCAGCCATGTTGGTACAAAATCCCTACATAACTGTGC GCAGCGATGGGAGCCTCCATATTGAAAGAGTTCGACTTCAGGATGGAGGCGAATATACTTGTGTGGCCAGTAATGTTGCTGGAACCAATAACAAAACAACCTCTGTAGCCGTGCATGTTCTGCCTACC ATTCAGCACGGACAGCAGATACTCAGCACCATTGAAGGCGTTCCAGTAACTTTGCCATGCAGAGCGAGTGGGATCCCCAAGCCGTCTATCACTTGGTCGAAGAAAGGAGAGCTGATTTCAACGGGCAA TGCCAAGTTTTCTGCAGGGGCTGATGGGAGTCTGTATGTGGTGTCACCAGGAAGCGAGGAGAGTGGAGAGTACATCTGCACAGCCACCAATGCAGCCGGCTATGCCAAGAGGAAAGTGCAGCTGACTG TCTATGTAAGACCCAGAGTGTTCGGGGACCAAAGAGGACTGTCCCAAGATAAGCCTGTGGAGATCTCTGTCCTGGCTGGGGAGGAGGCAACCCTTCCCTGTGAAGCGAAGAGCTTACCTCCACCAATC ATTACCTGGGCCAAAGATAGCCAGCTCATCTCTCCGTTTTCTCCAAGACACACGTTCCTGCCTTCTGGCTCAATGAAGATCACAGAAACACGCATTTCAGACAGTGGGATGTATCTGTGTGTGGCCAC AAATATTGCTGGGAATGTGACTCAATCCGTTAAATTAAGCGTCCATGTTCCTCCAAAAATACAGCATGGAAATAGACACCTAAAAGTCCAAGTCGGCCAGAGAGTGGACATCCCGTGCAATGCCCATG GGTCTCCTCCTCCCGTCATCACCTGGTTTAAAAGTGGAAGGCCCATGCCGTTCAATGGAGTGCAGCATCCTGGTAGCCCAGATGGAATGCTGACCATTGAGCAGACCACACTCTCAGATGCTGGCACA TACACATGCACTGCCACAAACATAGCCGGAAGTGATGAAGCAGAGGTCACCTTGCATGTCCAAGAACCACCCACAGTGGAAGACCTGCAACCTCCCTTTAACACTCCGTTCCAAGAACGGTTGGCCAA TCAGCGCATGGCATTTCCATGCCCTGCAAAAGGTACTCCTAAACCAACCATCAAGTGGTTACACAATGGTAAAGAGGTGACAGGGCAGGAGCCTGGTGTCTCTATCTTGGAAGATGGAGCGCTATTGG TAATCGCTTCTGTTACACCACTCAACAATGGCGAGTACATCTGTGTGGCCGTCAACGAAGCCGGGACCACAGAAAGGAAATACAACCTCAGAGTTCACGTTCCACCAGTAATTAAAGATAAAGAACAT GTGAGCAATGTGTCCGTGTTGGTAAACCAACTGGCCAGCCTCTACTGTGAAGTAGAAGGAACTCCGTCCCCGGTCATAATGTGGTATAAGGATGACATCCAGGTGACAGAAAGCAGCACTGTTCAGAT CGTGAATAATGGAAAGATTCTAAAACTCTTCAAGGCGTCTGCAGAGGATACCGGAAGATACTCCTGCAAAGCGATTAATATTGCAGGAACCTCTCAGAAGGACTTTAGTGTGAATGTACTAGTTCCAC CCAGCATACAAGGTGCCGGCTCCCCAAATGAAGTCTCAGTTGTTCTTAACCACAACATCACCCTACAGTGCCCGGTCAGAGGCACTCCCTTTCCGGCTATTCACTGGTTCAAGGATGGCAAGCCTTTA TTTTTGGGGGATCCTAACATTGAACTCTCAGACAGAGGACAGAATTTACATCTGAGAAATGCACGGAGAAGTGACAAGGGGCGCTACCAATGTTCTGTGTCCAATGCAGCTGGCAAGCAAGCCAAGGA TATAAAGCTCACTCTCTACGTTCCACCTAGTATTAAAGGAGGCAATGTCACCACAGAAATATCGGCATTGCTCAACAGCGTAGTTAAACTGGAATGTGAGACGCGGGGGCTTCCTGTGCCTGCCATTA CTTGGTATAAGGATGGCCAGGTGGTCACATCCAGCTCACAAGCACTTTATATTGACAAAGGACAATTTCTCCACATCCCGAGAGCACAAGTCTCTGACTCAGCAACGTATACATGTCACGCATCCAAT GTTGCTGGAACAGCCGAAAAATCATTCCATGTTGACATCTATGTCCCTCCAATAATTGAAGGTGACTTGACCACTCCTTCAAGTAAGCAGGTCGTTGTTGGTCAGTCATTGGTCCTGGAGTGTAAAGC TGTTGGCAACCCTCCCCCCGTCCTTACTTGGTTAAAAGATGGCGTGCCTGTGAAAGCCAGCGACAACATCCACATAGAAGCTGGTGGGAAGAAACTCGAAATCTTGAGTGCCCTAGAAGTTGATAGGG GACAATACATATGTGTGGCTACCAGTGTGGCAGGAGAGCGGGAAATCAAGTATGAAGTTGATGTCTTGGTGCCACCGGCTGTGGAAGGAGGAGATGAGACATCTTACTTCATTGTGCTGGCAAATAAC TTACTGGAGCTAGACTGTCAGGTCTCCGGCTCTCCCCCACCAACTATCATGTGGCTAAAAGGCGGTCAGTTAATTGATGAACGAGATGGATTCAAGATCTTACTAAGTGGACGCAAACTGGTTATTGC TCAGGCTCAAGTGTCAGACACAGGCCTGTACCAGTGTGTGGCAACAAACGTTGCAGGGGATCGCAGGAAGGAGTTCGAAGTGACAGTGCACGTTCCTCCAACCATCAAGTCCTCAGACCTTCCTGAGA AGACTGTGGTGAGATACAAGCCAGTCAGCTTGCAGTGCATAGCCAACGGCATCCCAAACCCATCCATCACATGGTTGAAGGATGACCAGCCTGTGAACACTGCCCCAGGAAACCTCAGAATACAGTCT TCTGGTAGAGTTCTACAGATTGCCAAGGCTCTTTTGGAAGACGCTGGTAGATACACATGCGTGGCTACCAATGCAGCTGGAGAAGCACATCAGCACACCCAATTGCATGTGCATGAACCCCCCAGCCT GGATGATGGCGGGAAGATGCTGAACGAGAGCGTGGTGGTGAACAACCCCATTCAGCTGGAGTGTAAAGCCACAGGCAGTCCTGTTCCTGTTCTCACATGGTACAAAGACAGCCATCCACTCGCAGGCT CCACAAGTGCAACCTTCCTGAAGAGAGGGCAGATCCTTGAGATTGGAAGTGCTCAGATCTCAGATGCTGGCATCTACAAATGTGTAGCCATCAACTCTGCTGGAGCTACAGAATTGTTTTACAGCCTA CAAGTTCATGTGCCTCCTTCGATCTCAGGGAGCAGTTCCATGGTGGAGGTGGTGGTGAACAATCTAGCAAGGTTAGAATGTGAAGCCAGGGGCATCCCTGCCCCCAGTCTGACCTGGTTGAAAGATGG GAGTCCAGTCTCTAGCTTCTCTAATGGAATACAGGTTCTCTCAGGGGGTCGCATCTTGGCACTGACCAGTGCCCAAATGAGTGACACAGGAAGGTACACTTGCGTGGCCGTGAATGCTGCTGGGGAGA AACAAAGGGACTTTGACCTCAGAGTATATGCTCCACCCAATATTATGGGAGAAGAACAGAATGTCTCTGTCCTCATTAGCCAAACTGTGGAGTTATTTTGTCAAAGTGATGCTGTTCCCCCACCTACT CTGATGTGGTTCAAGGATGGCCGCCCTCTGCTGAAGAGACCGGGTCTCAGTATCTCTGAAAATGGAAGTGTGCTTATGATTGAAGATGCTCAGGCCGGAGACACTGGTCGATACACCTGTGAAGCGAC AAATGTTGCTGGGAAAACAGAGAAAAACTACAACGTTAACATCTGGGTACCTCCTAGTATTTATGGCTCTGATGAGCTCGTGCAACTCACAGCCATTGAAGGGAATCTTATCACTCTCCTATGTGAAT CAAGTGGAATTCCACCCCCAAATCTTACTTGGAAAAAGAAAGGTTCTCTGGTGTTGGCTGACGCTGCAGGACGTGTTCACATTTTATCTGGTGGCCGACGGTTACAAATTTCAATTGCTGAGAAAGCA GATGCAGGACTCTACACGTGTGTGGCATCCAACGTGGCTGGCATTGCAAAGAAAGAGTACAACCTTCAAGTGTATATCCGACCATCAATAGCCAACAGTGGCAGTCACCGCCCTGAGATTACTGTCAT CCGTGGGAGAAGTATTTCCTTGGAATGTGAGGTGCAGGGTATTCCTCAGCCAACAGTGACCTGGATGAAAGATGGCCGCCCCTTGTCCAAGGGAAAAGGAGTGGAAATCCTGGATGAAGGCCGCGTTC TTCAGCTGAAGAATGTTCACGTTTCTGACACAGGCCGTTATGTGTGCGTTGCTGTGAATGTAGCAGGAATGACTGACAAAAGATATGACTTAAGTGTCCACGTCCCTCCGAGCATCATCGGGAACCAC GGAGTCCCTGAGAACATCAGTGTGGTGGAAAAGAGTTCTGTATCCCTGACCTGTGAAGCCTCCGGCATCCCCCTGCCTTCCATAACCTGGCTGAAGGATGGTTGGCCTGTCAGCCTTGGCAGCTCTGT GAAGATTCTCTCAGGAGGCAGGATGCTGCGGTTGATGCAGACCAGACCAGAAGATGCTGGCCAGTATACATGTATTGTAAGGAATGCAGCTGGTGAAGACAGGAAAATGTTTGGACTTTCAGTATTAG TTCCTCCTCACATTGTGGGTGACAACACATTGGAAGATATAAAGATTAAAGAGAAACAGAGTGTTACACTGACTTGTGAAGTGAGAGGGAATCCTGTGCCACAGATCACATGGCACAAAGACGGACAG CTTCTCCAGGAAGACGAAGTACACCACATGATGTCTGGAGGCCGTTTTCTTCAGATCACCAATGCTCAAGTGTCCCACACAGGACGATACACGTGTCTGGCCTCTAATATAGCTGGTGACAAAAGCAA AAGTTTCAGTCTCAATGTGTTTGTATCTCCTACAATTGCTGGTGTAGACAGTGATGGCAGCCCCGAAGACGTTATTGTCATCCTTAACAGCCCCACTTCTCTAGTGTGTGAGGCATATTCCTATCCCC CGGCCACCATCACCTGGTTCAAGGACGGCGCGCCTTTAGAATCCAGCCGGAACCTTCGCATCCTTCCAGGAGGCCGTACTCTGCAGATCCTAAACGCACAGGAAGACAATGCCGGAAGATACTCATGT GTGGCCACTAATGAGGCTGGGGAGATGATAAAGCACTACGAAGTGAAGGTCTACATTCCGCCCATCATCAAGAAAGGGGACCTTTTGGGGACGGGTCTTTCCCCGAAGGAGGTGAAGATCAGAGTGAA CAGCAGCCTGACTTTGGAGTGTGAGGCTTACGCGATTCCATCTGCCTCCCTCCGCTGGTACAAGGACGGACAGCCCCTTAAATCAGATCATCATGTTAACATCGCTGAAAATGGGCACACTCTTCAAA TCAAGGAAGCTCAGATATCAGACACCGGGAGATACACCTGTGTGGCCTCTAACCTCGCAGGCGAAGATGAGTTGGATTTTGATGTGAATATCCAAGTTCCTCCAAGTTTTCAGAAACTCTGGGAAATA GGAAACATGTTAGACACCGGCAGGAGTGGAGAAGCCAAAGACGTGATCATCAACAACCCTATTTCTCTGCACTGTGAGACAAACGCTGCTCCTCCACCAACCCTTACATGGTACAAAGATGGCCGACC TCTGACCTCCAGTGACAGAGTGTTGATTTTGCCAGGAGGACGAGTGCTGCAGATTCCCCGGGCTAAAGTAGAAGATGCCGGGCGGTACACGTGTGTGGCCGTGAATGAAGCCGGGGAAGACTCCCTTC AGTATGACATCCATGTGCTCTTGCCACCAGTTATCAAGGGAGCAAACAGTGATCTTCCGGAAGAGGTCACCGTGCTGGTGAACAAGAGTGCACAGATGGAATGTTCATCCAGCGGTAGCCCAGCACCA AGGAATTTCTGGCAAAAAGATGGACAGCCCTTGCTAGAAGATGAACATCACAAGTTCCTATCTGATGGCAGGGTTCTTCAGATTCTAAATGCTCAAATAACAGATACCGGGAGGTATGTGTGTGTTGC TGAGAACACAGCTGGGAGTGCCAAGAAATACTTTAACCTCAACGTTCATGTTCCTCCAAGTGTCATTGGTCCTAACCATGAACATCTCTCTGTGGTTGTGAACCATTTCATCTCTTTGACCTGTGAAG TTTCTGGGTTCCCCCCTCCTGACCTCAACTGGCTCAAGAATGAACAGCCCATCAAGCCAAACACTAATGTTCTCATTGTGCCTGGTGGTCGAACTCTACAGATTATTCGGGCCAAGGTATCTGATGGC GGTGAATATACCTGCGTCGCTATCAACCAAGCCGGAGAAAGCAAGAAAAAGGTTTCCCTGACTGTTCATGTACCCCCAAGCATTAAGGATCACGGCAGCGAGTCTCTGTCTATAGTTAATGTAAGAGA GGGGACCTCGGTGTCATTGGAATGCGAGTCAAATGCTGTGCCCCCGCCAGTCATCACCTGGTCTAAGAATGGGCGGATGATACCGGATTCTAGCAACGTGGCGATTTTAACTGGTGGACAAATGCTAC ACATCAGGCGAGCCGAGGTGGCTGACACAGGCCAGTATGTATGTAGAGCTATAAATGTAGCAGGACGAGATGATAAAAATTTCCACCTCAATGTATATGTGCCCCCCACCATTGAAGGGCCTGAAACA GAAGTCATTGTGGAGACAATGAGCAATCCGGTGACATTGACTTGCGATGCCACTGGGATCCCTCCTCCCACCATAACATGGTTAAAGAACCACAAGCCCATAGAAAACTCTGACCCCCTTGAGGCTCA CATTTTGTCTGGAGGAAGCAAACTGCAAATTGCCCGACTTCAGCGTTCAAACCGTGGAAACTACACGTGTGTTGCATCCAATATGGAGGGAAAGGCTCAGAAAAATTATATCCTTTCCATTCAGGTCC CTCCAAGTGTTGCCGGTGCGGAAGTTCCAAGTGAAGTTAGTGTCCTTCTTGGGGAAAATGTGGAGCTGGTCTGTGATGCAGATGGCATTCCCATCCCTCGTCTACAGTGGCTTAGAGACGGAAAACCC ATAGTGAGTGGTGAAACAGAACGAGTCAGGGTCACCACAGATGGCAGCACACTAAATATTTACAGAGCCCTCACATCTGACATGGGAAAGTATACATGTGTGGCTACTAATCCTGCTGGAGAAGAAGA CCGAATATTTAACTTGAATGTCTATGTTCCACCTAAAATCCGAGGTAATAAGGAGGAGGCAGAGAAACTGATGGCTCTGGTAGACACGTCACTAAACATCGAATGCAAAGCCACGGGGACACCTCCAC CGCAGATCAGCTGGCTGAAGAACGGCCTTCCTCTGCCCATCTCTTCCCACATTCGCTTGCTGTCAGCAGGGCAGGCCATCAGGATCGTGAGAGCTCAGGTGTCTGATGTTGCTGTGTATACTTGTGTG GCCTCCAATAGAGCTGGGATAGATAGTAAGCGCTACAGCCTTCAAGTCTTTGTGCCACCGAATATGGACAACGCAATGGGAACAGAGGAAATCACACTTGTCAAAGGCAGTTCTACCTCTATGACGTG CTTTACAGATGGAGCCCCTACCCCTAGCATGTCTTGGCTCAGAGACGGCCAGCCTCTGGCGCTTGATGCTCATCTGACCATCGGCACTCAGGGGATGGTCCTTCAGCTCATCAAGGCAGACACGGAAG ATACTGGAAAGTACACCTGCGTTGCCTCAAATGAAGCTGGAGAAGTCAGCAAGCATTTTGTCCTGAAAGTCCTAGAACCGCCTCACATCAATGGATCTGAAGGGCCTGGAGAGGTATCCGTAATTGTA AATAACCCACTTGAACTGTCCTGCATTGCTTCTGGAATCCCTGCCCCTAAGATTTCCTGGATGAAAGATGGCCGGCCCTTTCTACAGACAGAGCAAGTGCAGACTCTAGAAGGAGGAGCTATTCTTCG AGTGTCCAGTGCGCAGGTGGAGGACACAGGAAGATACACCTGCCTGGCATCCAGTCCTGCAGGGGACGATGATAAAGAATATCTAGTGAGAGTACACGTGCCTCCTAACATTGCTGGAGTGGATGAAG CCCAGGACTTCACCGTGTTAAGGAACAGGCAGGTGACATTGGAATGCAAGTCCGACGCAGTGCCTCCACCTGTGATCATGTGGCTCAAAAATGGGGAGCAGTTACAGGCAACACCTCGAGTAAGAATC CTGTCTGGAGGCAGATACTTGCAAATTAATAATGCAGACCTGGGAGACACGGCCAATTATACCTGTGTCGCCAGCAACATCGCAGGAAAGACTACAAGAGAATTTATCCTCACTGTAAATGTTCCTCC AAGCATCAGTGGTGGTCCCCAGAGCCTTGTCACTCTCTTAAATAAGTCAATTGCCCTGGAATGCCTTGCTGAAGGCGTGCCATCACCCAGGATAACATGGAGAAAGGACGGTGTTGTTCTAGCTGAGA GCCATGCAAGATACTCCATCTTGGAAAATGGATTTCTTCACATTCAGTCAGCACATATCACAGATACCGGACGGTATTTGTGTATGGCAACCAATGTGGCTGGAACAGACCGTAGGCGAATAGATTTA CAAGTCCATGTTCCTCCCTCCATTGCTGCGGGTCCTACCAATGTAACAGTGACCGTGAACGTCCAAACTACTTTGGCTTGTGAAGCTACTGGGATACCAAAGCCATCAATCAACTGGAGAAAAGACGG ACATCTGCTTAATGTAGATCAAAATCAGAATTCATACAGACTCCTTTCCTCAGGTTCACTCATCATCATTTCCCCCTCTGTGGATGACACTGCCAGTTACGAGTGCACCGTGACAAGTGATGCTGGAG AGGACAAGAGAACAGTGGACCTCACTGTCCAAGTTCCTCCCACCATAGCTGATGAGCCTATGGATTTCCTGGTAACCAGACAGGCCCCAGCAGTCATGACCTGCTCTGCTTCTGGAGTTCCACTTCCC TCAATTCACTGGACCAAAAATGGCATAAGACTGCTTCCCAGGGGAGATGGCTATCGGATTCTGTCCTCAGGAGCCATTGAGATATCTGCTGCCCAGTTAAACCACGCAGGAAGATACACTTGCATTGC TCGGAATGCAGCAGGCTCAGTACACCGACATGTAACCCTTCGTGTTCAAGAGCCTCCATTCATTCAGCCCCAACCAAGTGAACTGGATGTCATTCTAAACAACCCCATCTTACTACCGTGTGAAGCAA CAGGCATACCCACGCCATTTATAACTTGGCAAAAAGAAGGCATCAACGTCATTACCTCAGGCAAGAGCCTTGCTGTTCTTCCCAGTGGCAGCTTACAGATCTCCAGAGCTGTTCAGGGGGATGCTGGC ACCTACATGTGTGTGGCTCAAAACCCAGCTGGTACAGCCTTGGGCAAGATCAAGCTGAATGTACAAGTTCCTCCAGCCATTAGTTCTCATCAAAAGGAATATGTTGTTACTATGGATAAGCCTGTCTC CCTCTTGTGTGAGACAGAGGGCTCCCCACCACCTGACATCACCTGGCATAAAGATGGGCATGCTCTCACTGAATCCATCCGCCAGCGCATCCTGAACTCAGGAGCTCTGCAGATAGCATTTGCTCAAC CCGATGATGCTGGTCAGTACACATGCATGGCCGCTAACATGGCGGGATCAAGCAGCATGAGCACCACACTCACCGTCCATGTACCACCTAGGATCCAAAGCACAGAAGTACACTACACCGTCAACGAG AACTCTCAAGTTGTTCTCCCGTGTGTCGCTGATGGAATCCCCACGCCTGCAATTCACTGGGAAAGAGACAGCGTTCTTCTAGCCAACTTGTTAGGGAAGTACACTGCCCAGCCATATGGAGAACTCGT CTTGGAAAATGTTGTGCTGGAAGATGCTGGCACCTACACATGTGTTGCTAACAATGCTGCTGGTGAAGATACACATACTGTGACCCTGACTGTTCATGCCCTTCCCACTTTTACCGAACTTCCTGGAG ACCTGTCATTAAATAAAGGAGAGCAGCTACGGCTAAGTTGTAAAGCCGTTGGCATTCCATTGCCCAAACTAACGTGGACCTTCAACAACAATATTATTCCAGCCCACTTTGACAGCGTCAATGGACAC AGTGAACTTGTTATTGAGAAGGTGTCAAAGGAGGACTCGGGCACTTACGTGTGTACAGCAGAGAACAGCGTTGGCTTTGTGAAAGCGATTGGATTTGTTTATGTGAAAGAGCCCCCAGTCTTCAAAGG TGATTACCCCTCTAACTGGATTGAACCACTCGGCGGGAATGCAATCCTAAATTGTGAAGTGAAAGGAGACCCTGCCCCAACCATCCAATGGAGTCGCAAGGGGGCTGACGTAGAGATTAGCCACAGGA TCCGACAACTGGGTAATGGCTCCTTGGCTATCTACGGTACCGTGAATGAAGACGCTGGTGACTATACATGTGTTGCTGCCAATGAGGCCGGGGTGGTAGAGCGCAGTATGAGTCTGACTCTGCAAAGT TCTCCCATGATCACTCTTGAGCCTGTGGAAACCATTGTGGATGCCGGTGGCAGAGTCACATTGGATTGTCAAGCAGCTGGTGAACCTCAGCCAACCATCACATGGTCCCGTCAAGGGCGCCCCATCCC CTGGGATAACCGACTTACCATGCTGCCTAATAGTTCATTATACATCGCTGCTGCTCGCAAGGAAGACACCTCTGAATATGAGTGTGTTGCCCGAAACTTGATGGGCTCTGTCCTTGTCAGAGTGCCCG TCATAGTCCAGGTGCATGGTGGGTTTTCGTTGTGGTCTGCCTGGAGGTCCTGCAGTGTCACCTGTGGAAAAGGCATCCAAAAGAGGAGCAGGCTATGCAACAACCCTCCTCCAGCCAATGGAGGGAGG CCATGCCAAGGCTCAGAGTCAGAAGCACGACAGTGTCAAAATAAGTTGTGTCCAGTGGATGGTCACTGGTCAGAATGGAGCTTCTGGGAAGAATGCTCAAGAAGCTGTGGGCATGGCAACCAAACTAG GACGAGAACTTGCAGTAACCCACCGGCTCAGCATGGTGGGCGGCCATGTGAGGGGTATGCTGTGGAAACCATCATGTGTAACATTCGGCCTTGCCCAGTCCATGGTGTGTGGAATGCTTGGCAACCTT GGGGTTCGTGCAGCAAAAGCTGTGGAAAAGGCAGTCAGACAAGAACAAGACTTTGCAACAGCCCGCCACCGTCATTTGGTGGGGCCTACTGCAATGGAGCAGAAACCCAGATGCAAGTCTGCAATGAG AGACACTGTCCAGTGGATGGCAAGTGGGCAGCTTGGACCAGTTGGAGTACCTGCACTGTATCCTGTGGAGGAGGTACCAGGAAGAGAACAAGGGACTGTTCTGACCCAGTGCCACAGTATGGAGGAAA CAAATGCGAAGGGACTGGTGTCCAGAGTGACTTTTGCAATAGTGACCCTTGTCCAACCCATGGCAACTGGAGCCCTTGGAGTGGCTGGGGGATGTGCAGTCGGACATGCAATGGAGGGCAGATGAGAC GGTACCGCACATGTGATAATCCACGGCCCTCCAATGGAGGAAGAGCCTGTGGGGGTCCAGATACCCAGATCCAGAGGTGTAATACTGACATGTGTCCTGTGGATGGAAGTTGGGGAACATGGCATAGT TGGAGTCATTGTTCTGTCTCTTGCGGGGGAGGTGAAAGAACTCGAAAGCGGTTATGTGACAATCCTGTGCCCTCTAAAAGTGGCCGTTCCTGTCCAGGAGATGCCACCCAAGTCTCCAGATGCAACAT GCAGGCTTGTCCGGGTGGACCCCAACGAGCCAGAGGGAGTGTTATTGGGAATATTAATGATATTGAGTTTGGAATCGCTTTCCTTAATGCCACAATAACAGATAGCCCTAACTCTGATACAAGAATAA TACAGGCCACGATTACCAATGTGCCTCGCAGTCTGGGTCCAGCAATGAGAAAGATCATTTCTATCCTAAATCCCATTTACTGGACCACAGCAAAGGAAATAGGGGAAGCAGTCAATGGCTTTACCCTC ACTAACGCAGTCTTCAAAAGAGAGACGCAAGTGGAATTTGCAACTGGAGAGGTCTTGAGGATGACACATGTGGCTCGGGGCTTAGATTCCGACGGCGCATTGCTGCTTGACGTCATTGTGAGTGGCCA TGTCCTGCAGCTCCACTCACCTGCTGAAGTTAGTGTGAAGGATTACACAGAGGACTACATTCAAACAGGACCTGGGCAGCTCTACGCCTACTCAACCCGGCTGTTCACCATCGATGGCATCAGTGTCC CCTATACATGGAACCACACCATTTTCTATGATCAGGCCTGGGGGAAAATGCCTTTCTTAGTAGAAACACTTCATGCATCTTCTGTAGAATCTGACTACAACCAACTAGAGGAGACACTGGGTTTCAAA ATCCACGCTTCAATCTCCAAAGGAGATCGCAGTAACCAGTGCCCCTCTGGTTTTATCTTAGACTCAGCTGGACCCTTCTGTGCTGATGAGGATGAATGCACAGCTGGGAACCCCTGCTCTCATACCTG CCACAATGCCATAGGAGCCTATTATTGCTCCTGTCCCAAAGGCCTCACCATAGCTGCCGATGGGAGAACCTGTCAAGACATTGATGAGTGTGCTTTGGGTGGACATACCTGTCATGCTGGTCAAGACT GTGACAATACCATTGGATCCTATCGCTGTGTGGTCCACTGCGGAACAGGCTTCCGGAGAACCTCTGATGGGCTGAGCTGTCAAGATATTAATGAATGTCAGGAATCCAGCCCCTGCCACCAGCGGTGT TTCAATGTCATAGGAAGTTTCCACTGTGGCTGTGAAGCTGGCTATCAACTCAAAGGCAGAAAGTGCATCGATGTGAACGAATGTAGACAGAGCGTGTGCAGACCAGACCAGCACTGTAAGAACACCCG CGGTGGCTACAAGTGCATTGATCTCTGTCCAAGTGGAATGACCAAGGCTGAGAATGGGACCTGCATTGACATTGATGAGTGCAAAGATGGGACCCACCAATGCAGATATAACCAAATATGTGAGAACA CGAGAGGCAGCTACCGGTGTGCATGCCCAAGGGGTTATCGGTCTCAAGGAGTTGGAAGACCCTGCGTTGACATTAATGAATGTGACCAAGTACCTAAACCTTGTGCACATCAGTGCTCCAACAGCCCC GGCAGCTTCAAGTGTATCTGTCTGCCAGGACAACATTTATTAGGGGATGGGAAATCTTGCGCTGGATTGGAGAGGCTGTCGAGTTATGGCACTCAGTACAGTAGCTATGACCTTGAGCGGTTCTCCCC TGTGAGAAGTGGCTATCAACCTCGGCAGCATACCAGACAGCAGTCACAGCTCTACAGCTCCTACTCAGAGTATAGGAACAGCAGAGCATCTTTCTCCAGGAGTAGAAGGACTATTAGGAAAACTTGCC CTGAAGGCTCTGAGGCAAACCATGAAACATGTGTAGATATTGATGAATGTCAAAACAGAGATACTTGCCAACATGAGTGTAAAAACACGATCGGAAGCTACCAGTGCGTCTGCCCACCGGGTTATCGA CTCATGCTCAATGGGAAAACATGCCAAGATGTCGATGAGTGCTTGGAGCAGAATGTACGCTGTGGGCCGAATCGCATGTGTTTCAACATGAGAGGAAGCTATCAGTGCATCGACACACCCTGTCCACC CAACTACCAACGAGATCCTGTTTTGGGGTTCTGCCTCAAGAACTGCCCACCCAATGACTTGGAATGCACCTTGAGCCCCTATGCCTTGGAATATAAACTTGTCTCCCTCCCATTTGGAATAGCTGCCA ATCAAGATTTAATCCGGCTGGTTGCATACACACAGGATGGAGTGATGCATCCCAGGACAACTTTCCTCATGGTAGATGAGGAACCAGCTGTCCCTTTTGCCTTAAGGGATGAAAACCTGAAAGGAGTC GTGTACACTACACGTCCACTACGAGAGGCAGAGACCTACCGCATGAAGGTGCGGGCTTTATCCTACAGTGCCAACGGGACCATTGAGTATCAGACTACATTCATAGTTTATATAGCTGTGTCTGCCTA TCCATACTAGGAAGTACTCCAGAATTGAGTCCAAATATTTAAACTGCATTGATCTAGCAATCAAGGACCTCTACAATTTACTATCTCTTGAACAGTTGCAATCTTGGCAACTTGAAAATGGTGCTGTG CTGTTATGTATGTGTTCCTTGGTACTGCTGAAGTATCTGTATGATCCCACTGTGGTCATGTATCTTTTAGTACGTTCTAGAAGAGTCCTTTCTTATTGTCTTTATTTATTACACTGGAGCAGTTACTT CCCAAGGATTATTCTGATCAGCTCACAGGACATGTCAGTGATATTGTATAGTAGCATAGTAGCTAAGATCATTTTCTTGGAAACAATATAGAACAAAACAAAACAAAAAACTAGTTCAAATACTTTTT GAACATTTTGGCTATTCTTAAAATGGTAAAAACCAGCTATTATGTGTTTTGATAAAAGCTTATGCCATATTATACATTTTTAAAATATTGAAATAACACTTATATCTTTCATTTTAAGGTTAAAAATA AGAAACATCACTTTTCTGAAATATAGTGCAGATACAAGAAAGTTTGCTTGATCCGAAATGGATCTTATCTTTATTAAATACTCAAGATACATTACCTGAGGTTCTGCGAAATCATGTGAACTTTGTAC TATGTTATCAGAAAATTACTTTCCCTTTAAAGAATTGCCCATGGCCTAGGCCTTTGACATTTTGGTATTCACTCAGCTCCATAACTTTTACATTCCATATCTATCTGTCAAATAAAATTATTTTAATA CATAACAATAGAACAGATTTCTTGATTATTGTACTCATGTATGTTCAAGTAACGTGTTAAACGTCAATACACTGTACATGGTGGTAACAGACTCTGTAAGCAATTGTCAAGATGTATTCTATTTTTAT GAAGTGTATATATTACCTTAGTGTGTATTTTCTATATAATATCTTGATGGACTCTTTTATAAAATTATTTTATAAAAAAATTACAGTAAAATAAGCCTAAATAAAATTTTCACCTTTTTCTTAATAAC CTAAAA
hide sequence
RefSeq Acc Id:
XM_039090456 ⟹ XP_038946384
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 13 65,165,532 - 65,575,754 (-) NCBI mRatBN7.2 13 62,615,461 - 63,026,663 (-) NCBI
RefSeq Acc Id:
XM_039090457 ⟹ XP_038946385
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 13 65,165,532 - 65,634,681 (-) NCBI mRatBN7.2 13 62,615,461 - 63,084,515 (-) NCBI
RefSeq Acc Id:
XM_039090458 ⟹ XP_038946386
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 13 65,165,532 - 65,634,681 (-) NCBI mRatBN7.2 13 62,615,461 - 63,084,515 (-) NCBI
RefSeq Acc Id:
XM_039090459 ⟹ XP_038946387
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 13 65,165,532 - 65,575,754 (-) NCBI mRatBN7.2 13 62,615,461 - 63,026,663 (-) NCBI
RefSeq Acc Id:
XM_039090460 ⟹ XP_038946388
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 13 65,165,532 - 65,414,498 (-) NCBI mRatBN7.2 13 62,615,461 - 62,891,492 (-) NCBI
RefSeq Acc Id:
XM_039090461 ⟹ XP_038946389
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 13 65,262,279 - 65,634,681 (-) NCBI mRatBN7.2 13 62,712,246 - 63,084,515 (-) NCBI
RefSeq Acc Id:
NP_001258221 ⟸ NM_001271292
- Peptide Label:
precursor
- UniProtKB:
F1M4Q3 (UniProtKB/TrEMBL)
- Sequence:
MIAQELVHTVFLVALFHSSLAGVGTPQSESRAEEIPEGASTLAFVFDVTGSMYDDLVQVIEGASKILETSLKRPKRPLYNFALVPFHDPEIGPVTITTDPKKFQYELRELYVQGGGDCPEMSVGAIKI ALEISLPGSFIYVFTDARSKDYRLTHEVLQLIQQKQSQVVFVLTGDCDDRNHIGYKVYEEIASTSSGQVFHLDKKQVNEVLKWVEEAVQASKVHLLSTDHLEHAVNTWKIPFDPSLKEVTVSLSGPSP VIEIRNPFGKLIKKGFGLNELLNIHNSAKVVNVKEPEAGMWTVKTSSSGRHSVRLTGLSTIDFRAGFSRKPTLDFKKTMSRPVQGIPTYVLLNTSGISSPARVDRLELLSISGGSLKTIPVKHYPDRK PYGIWNISDFIPPDEAFFLKVTGYDKEDYLFQRVSSVSFSSIVPDAPKVTMPTRTSGYYLQPGRILCSVESLLPFTLSFVRNGIALGVEQYLKESASVPWDFPKVTLSDEGFYECIAMNSAGTGRAQT FFDVSEPPPIIQVPNNVTVTPGERAVLACLVISAVDYNLTWQRSGRDVRLADSARIRTLANLSLELRSVKIGDAGEYRCVVSSEGGSAAASVFLTVQEKPKVTVMPRNQSFTGGSEVSIMCSATGYPK PKIVWTINEMFILGSHRYRMTAEGTLFIKNAVPKDAGTYSCLASNEAGTDEQTSTLRYIEAPKLVVVQSELLVALGDTTVMECKTSGIPPPQVKWFKGDLELRPSTFLSIDPLMGLLKIQETQDLDAG DYTCVAANDAGRATGSLTLDVGSPPVFIQEPSDVSMEIGSNVTLPCYVQGYPEPKIKWRRLDNMPVFSKPFSVSSISQLRTGALFISNLWASDKGTYICEAENQFGKIQSQTTVTVTGLVAPLIGISP SKASVIEGQPLTLPCTLLAGNPIPERRWMKNSAMLVQNPYITVRSDGSLHIERVRLQDGGEYTCVASNVAGTNNKTTSVAVHVLPTIQHGQQILSTIEGVPVTLPCRASGIPKPSITWSKKGELISTG NAKFSAGADGSLYVVSPGSEESGEYICTATNAAGYAKRKVQLTVYVRPRVFGDQRGLSQDKPVEISVLAGEEATLPCEAKSLPPPIITWAKDSQLISPFSPRHTFLPSGSMKITETRISDSGMYLCVA TNIAGNVTQSVKLSVHVPPKIQHGNRHLKVQVGQRVDIPCNAHGSPPPVITWFKSGRPMPFNGVQHPGSPDGMLTIEQTTLSDAGTYTCTATNIAGSDEAEVTLHVQEPPTVEDLQPPFNTPFQERLA NQRMAFPCPAKGTPKPTIKWLHNGKEVTGQEPGVSILEDGALLVIASVTPLNNGEYICVAVNEAGTTERKYNLRVHVPPVIKDKEHVSNVSVLVNQLASLYCEVEGTPSPVIMWYKDDIQVTESSTVQ IVNNGKILKLFKASAEDTGRYSCKAINIAGTSQKDFSVNVLVPPSIQGAGSPNEVSVVLNHNITLQCPVRGTPFPAIHWFKDGKPLFLGDPNIELSDRGQNLHLRNARRSDKGRYQCSVSNAAGKQAK DIKLTLYVPPSIKGGNVTTEISALLNSVVKLECETRGLPVPAITWYKDGQVVTSSSQALYIDKGQFLHIPRAQVSDSATYTCHASNVAGTAEKSFHVDIYVPPIIEGDLTTPSSKQVVVGQSLVLECK AVGNPPPVLTWLKDGVPVKASDNIHIEAGGKKLEILSALEVDRGQYICVATSVAGEREIKYEVDVLVPPAVEGGDETSYFIVLANNLLELDCQVSGSPPPTIMWLKGGQLIDERDGFKILLSGRKLVI AQAQVSDTGLYQCVATNVAGDRRKEFEVTVHVPPTIKSSDLPEKTVVRYKPVSLQCIANGIPNPSITWLKDDQPVNTAPGNLRIQSSGRVLQIAKALLEDAGRYTCVATNAAGEAHQHTQLHVHEPPS LDDGGKMLNESVVVNNPIQLECKATGSPVPVLTWYKDSHPLAGSTSATFLKRGQILEIGSAQISDAGIYKCVAINSAGATELFYSLQVHVPPSISGSSSMVEVVVNNLARLECEARGIPAPSLTWLKD GSPVSSFSNGIQVLSGGRILALTSAQMSDTGRYTCVAVNAAGEKQRDFDLRVYAPPNIMGEEQNVSVLISQTVELFCQSDAVPPPTLMWFKDGRPLLKRPGLSISENGSVLMIEDAQAGDTGRYTCEA TNVAGKTEKNYNVNIWVPPSIYGSDELVQLTAIEGNLITLLCESSGIPPPNLTWKKKGSLVLADAAGRVHILSGGRRLQISIAEKADAGLYTCVASNVAGIAKKEYNLQVYIRPSIANSGSHRPEITV IRGRSISLECEVQGIPQPTVTWMKDGRPLSKGKGVEILDEGRVLQLKNVHVSDTGRYVCVAVNVAGMTDKRYDLSVHVPPSIIGNHGVPENISVVEKSSVSLTCEASGIPLPSITWLKDGWPVSLGSS VKILSGGRMLRLMQTRPEDAGQYTCIVRNAAGEDRKMFGLSVLVPPHIVGDNTLEDIKIKEKQSVTLTCEVRGNPVPQITWHKDGQLLQEDEVHHMMSGGRFLQITNAQVSHTGRYTCLASNIAGDKS KSFSLNVFVSPTIAGVDSDGSPEDVIVILNSPTSLVCEAYSYPPATITWFKDGAPLESSRNLRILPGGRTLQILNAQEDNAGRYSCVATNEAGEMIKHYEVKVYIPPIIKKGDLLGTGLSPKEVKIRV NSSLTLECEAYAIPSASLRWYKDGQPLKSDHHVNIAENGHTLQIKEAQISDTGRYTCVASNLAGEDELDFDVNIQVPPSFQKLWEIGNMLDTGRSGEAKDVIINNPISLHCETNAAPPPTLTWYKDGR PLTSSDRVLILPGGRVLQIPRAKVEDAGRYTCVAVNEAGEDSLQYDIHVLLPPVIKGANSDLPEEVTVLVNKSAQMECSSSGSPAPRNFWQKDGQPLLEDEHHKFLSDGRVLQILNAQITDTGRYVCV AENTAGSAKKYFNLNVHVPPSVIGPNHEHLSVVVNHFISLTCEVSGFPPPDLNWLKNEQPIKPNTNVLIVPGGRTLQIIRAKVSDGGEYTCVAINQAGESKKKVSLTVHVPPSIKDHGSESLSIVNVR EGTSVSLECESNAVPPPVITWSKNGRMIPDSSNVAILTGGQMLHIRRAEVADTGQYVCRAINVAGRDDKNFHLNVYVPPTIEGPETEVIVETMSNPVTLTCDATGIPPPTITWLKNHKPIENSDPLEA HILSGGSKLQIARLQRSNRGNYTCVASNMEGKAQKNYILSIQVPPSVAGAEVPSEVSVLLGENVELVCDADGIPIPRLQWLRDGKPIVSGETERVRVTTDGSTLNIYRALTSDMGKYTCVATNPAGEE DRIFNLNVYVPPKIRGNKEEAEKLMALVDTSLNIECKATGTPPPQISWLKNGLPLPISSHIRLLSAGQAIRIVRAQVSDVAVYTCVASNRAGIDSKRYSLQVFVPPNMDNAMGTEEITLVKGSSTSMT CFTDGAPTPSMSWLRDGQPLALDAHLTIGTQGMVLQLIKADTEDTGKYTCVASNEAGEVSKHFVLKVLEPPHINGSEGPGEVSVIVNNPLELSCIASGIPAPKISWMKDGRPFLQTEQVQTLEGGAIL RVSSAQVEDTGRYTCLASSPAGDDDKEYLVRVHVPPNIAGVDEAQDFTVLRNRQVTLECKSDAVPPPVIMWLKNGEQLQATPRVRILSGGRYLQINNADLGDTANYTCVASNIAGKTTREFILTVNVP PSISGGPQSLVTLLNKSIALECLAEGVPSPRITWRKDGVVLAESHARYSILENGFLHIQSAHITDTGRYLCMATNVAGTDRRRIDLQVHVPPSIAAGPTNVTVTVNVQTTLACEATGIPKPSINWRKD GHLLNVDQNQNSYRLLSSGSLIIISPSVDDTASYECTVTSDAGEDKRTVDLTVQVPPTIADEPMDFLVTRQAPAVMTCSASGVPLPSIHWTKNGIRLLPRGDGYRILSSGAIEISAAQLNHAGRYTCI ARNAAGSVHRHVTLRVQEPPFIQPQPSELDVILNNPILLPCEATGIPTPFITWQKEGINVITSGKSLAVLPSGSLQISRAVQGDAGTYMCVAQNPAGTALGKIKLNVQVPPAISSHQKEYVVTMDKPV SLLCETEGSPPPDITWHKDGHALTESIRQRILNSGALQIAFAQPDDAGQYTCMAANMAGSSSMSTTLTVHVPPRIQSTEVHYTVNENSQVVLPCVADGIPTPAIHWERDSVLLANLLGKYTAQPYGEL VLENVVLEDAGTYTCVANNAAGEDTHTVTLTVHALPTFTELPGDLSLNKGEQLRLSCKAVGIPLPKLTWTFNNNIIPAHFDSVNGHSELVIEKVSKEDSGTYVCTAENSVGFVKAIGFVYVKEPPVFK GDYPSNWIEPLGGNAILNCEVKGDPAPTIQWSRKGADVEISHRIRQLGNGSLAIYGTVNEDAGDYTCVAANEAGVVERSMSLTLQSSPMITLEPVETIVDAGGRVTLDCQAAGEPQPTITWSRQGRPI PWDNRLTMLPNSSLYIAAARKEDTSEYECVARNLMGSVLVRVPVIVQVHGGFSLWSAWRSCSVTCGKGIQKRSRLCNNPPPANGGRPCQGSESEARQCQNKLCPVDGHWSEWSFWEECSRSCGHGNQT RTRTCSNPPAQHGGRPCEGYAVETIMCNIRPCPVHGVWNAWQPWGSCSKSCGKGSQTRTRLCNSPPPSFGGAYCNGAETQMQVCNERHCPVDGKWAAWTSWSTCTVSCGGGTRKRTRDCSDPVPQYGG NKCEGTGVQSDFCNSDPCPTHGNWSPWSGWGMCSRTCNGGQMRRYRTCDNPRPSNGGRACGGPDTQIQRCNTDMCPVDGSWGTWHSWSHCSVSCGGGERTRKRLCDNPVPSKSGRSCPGDATQVSRCN MQACPGGPQRARGSVIGNINDIEFGIAFLNATITDSPNSDTRIIQATITNVPRSLGPAMRKIISILNPIYWTTAKEIGEAVNGFTLTNAVFKRETQVEFATGEVLRMTHVARGLDSDGALLLDVIVSG HVLQLHSPAEVSVKDYTEDYIQTGPGQLYAYSTRLFTIDGISVPYTWNHTIFYDQAWGKMPFLVETLHASSVESDYNQLEETLGFKIHASISKGDRSNQCPSGFILDSAGPFCADEDECTAGNPCSHT CHNAIGAYYCSCPKGLTIAADGRTCQDIDECALGGHTCHAGQDCDNTIGSYRCVVHCGTGFRRTSDGLSCQDINECQESSPCHQRCFNVIGSFHCGCEAGYQLKGRKCIDVNECRQSVCRPDQHCKNT RGGYKCIDLCPSGMTKAENGTCIDIDECKDGTHQCRYNQICENTRGSYRCACPRGYRSQGVGRPCVDINECDQVPKPCAHQCSNSPGSFKCICLPGQHLLGDGKSCAGLERLSSYGTQYSSYDLERFS PVRSGYQPRQHTRQQSQLYSSYSEYRNSRASFSRSRRTIRKTCPEGSEANHETCVDIDECQNRDTCQHECKNTIGSYQCVCPPGYRLMLNGKTCQDVDECLEQNVRCGPNRMCFNMRGSYQCIDTPCP PNYQRDPVLGFCLKNCPPNDLECTLSPYALEYKLVSLPFGIAANQDLIRLVAYTQDGVMHPRTTFLMVDEEPAVPFALRDENLKGVVYTTRPLREAETYRMKVRALSYSANGTIEYQTTFIVYIAVSA YPY
hide sequence
Ensembl Acc Id:
ENSRNOP00000076253 ⟸ ENSRNOT00000093666
Ensembl Acc Id:
ENSRNOP00000033710 ⟸ ENSRNOT00000030971
Ensembl Acc Id:
ENSRNOP00000068149 ⟸ ENSRNOT00000076697
Ensembl Acc Id:
ENSRNOP00000067981 ⟸ ENSRNOT00000076776
RefSeq Acc Id:
XP_038946385 ⟸ XM_039090457
- Peptide Label:
isoform X2
- UniProtKB:
F1M4Q3 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038946386 ⟸ XM_039090458
- Peptide Label:
isoform X3
- UniProtKB:
F1M4Q3 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038946387 ⟸ XM_039090459
- Peptide Label:
isoform X4
- UniProtKB:
F1M4Q3 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038946384 ⟸ XM_039090456
- Peptide Label:
isoform X1
- UniProtKB:
F1M4Q3 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038946388 ⟸ XM_039090460
- Peptide Label:
isoform X5
- UniProtKB:
F1M4Q3 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_038946389 ⟸ XM_039090461
- Peptide Label:
isoform X6
RGD ID: 13698883
Promoter ID: EPDNEW_R9406
Type: single initiation site
Name: Hmcn1_1
Description: hemicentin 1
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 13 68,360,660 - 68,360,720 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2008-04-30
Hmcn1
hemicentin 1
Hmcn1_predicted
hemicentin 1 (predicted)
'predicted' is removed
2292626
APPROVED
2006-03-30
Hmcn1_predicted
hemicentin 1 (predicted)
RGD1564772_predicted
similar to OTTHUMP00000065631 (predicted)
Symbol and Name updated
1299863
APPROVED
2006-03-07
RGD1564772_predicted
similar to OTTHUMP00000065631 (predicted)
LOC289094
similar to OTTHUMP00000065631
Symbol and Name status set to approved
1299863
APPROVED
2006-02-09
LOC289094
similar to OTTHUMP00000065631
Symbol and Name status set to provisional
70820
PROVISIONAL